Pediatric Musculoskeletal Imaging Guidelines
Customize your policy alerts
Sign up for all evicore policy alerts
Know when evicore releases new policies or updates existing guidance.
Monitor payer policy activity
Coverage and utilization guidelines for pediatric musculoskeletal imaging procedures used by Cigna and administered by eviCore; intended to guide medical necessity and coverage determinations for providers and reviewers.
No material clinical or coverage changes in this revision.
Coverage and Medical Necessity Criteria
inv-01: General prerequisites and modality guidance
Covered when ALL of the following are met
Meaningful technological contact (telehealth, telephone, secure messaging) can serve as a pertinent clinical evaluation.
Plain x-ray can rule out conditions not requiring advanced imaging (eg, acute/healing fracture, osteomyelitis, bone tumors amenable to biopsy or radiation).
Conservative care examples include R.I.C.E., NSAIDs, analgesics, corticosteroids, viscosupplementation, home exercise, physical medicine, splinting/casting/bracing.
If IV access will already be present for anesthesia and no contraindication exists, acquiring non-contrast and contrast sequences in the same session may avoid repeat anesthesia; limit GBCA use to situations where added information is necessary.
inv-02: Acute Fracture (PEDMS-2.1)
Acute Fracture — Covered when criteria below are met
inv-03: Joint-Adjacent Fracture (PEDMS-2.2)
Joint-Adjacent Fracture — Covered when criteria below are met
inv-04: Growth Plate Injuries (PEDMS-2.3)
Growth Plate Injuries (Salter-Harris) — Covered when criteria below are met
inv-05: Osteochondral or Chondral Fractures, Including Osteochondritis Dissecans (PEDMS-2.4)
Osteochondral or Chondral Fractures — Covered when criteria below are met
inv-06: Stress/Occult Fracture (PEDMS-2.5)
Stress/Occult Fracture — Covered when criteria below are met
inv-07: Stress/Occult Fracture Imaging Criteria
Covered when criteria below are met
inv-08: Compartment Syndrome
Covered stance
inv-09: Soft Tissue and Bone Masses
Covered when ALL of the following are met (per subcategory conditions below)
inv-10: General evaluation — limping child
Covered when imaging follows the documented clinical evaluation and suspected etiology sequencing below.
inv-11: Limping child with suspected infection
Covered when imaging and procedures are used to exclude or confirm joint infection based on localization.
inv-12: Limping child without evidence of trauma or infection
Covered when imaging is directed by clinical differential and initial ultrasound/x‑ray findings.
inv-13: Developmental dysplasia of the hip (DDH) — screening and follow‑up
Covered when ultrasound or radiograph use matches age and risk criteria.
inv-14: Avascular necrosis / Legg‑Calvé‑Perthes disease
Covered when imaging follows initial radiograph then advanced imaging as needed.
inv-15: AVN / Legg-Calvé-Perthes / Osteonecrosis Imaging
Covered when ANY of the following are present:
Early osteonecrosis may be seen on MR with normal x-ray; MRI indicated when x-ray negative/inconclusive and imaging will change management.
inv-16: Osteonecrosis in oncology and high-risk populations
Covered when ALL of the following are met:
MRI screening in pediatric oncology populations can detect subclinical lesions; prefer MRI to avoid ionizing radiation when feasible.
inv-17: Suspected Physical Child Abuse Imaging
Covered when ALL of the following are met (age-dependent rules included):
Repeat skeletal survey ~2 weeks when initial is abnormal/equivocal; contacts <12 months require neuroimaging and skeletal survey; contacts 12–24 months require skeletal survey; no routine imaging in asymptomatic contacts >24 months.
inv-18: Infection / Osteomyelitis
Covered when ANY of the following are met:
See limping child section for hip-specific infection rules and CRMO section for chronic disease.
inv-19: Infection/Osteomyelitis (PEDMS-8)
Covered when ALL of the following are met for infection/osteomyelitis guidance in pediatrics:
Ultrasound is medically necessary for effusion/soft tissue fluid collection and is not required prior to other advanced imaging.
inv-20: Foreign Body (PEDMS-9)
Covered imaging for foreign body evaluation:
inv-21: Juvenile Idiopathic Arthritis (PEDMS-10.1)
Juvenile Idiopathic Arthritis — imaging covered when criteria met:
MRI is not medically necessary for routine follow-up except annual TMJ MRI.
inv-22: Chronic Recurrent Multifocal Osteomyelitis (PEDMS-10.2)
Chronic Recurrent Multifocal Osteomyelitis (CRMO) imaging criteria:
Characteristic lesions commonly involve juxtaphyseal/periphyseal tibia and femur, clavicle, thoracolumbar spine.
inv-23: Inflammatory Muscle Diseases (PEDMS-10.3) & Juvenile Dermatomyositis
Inflammatory muscle diseases and juvenile dermatomyositis imaging:
Routine screening for occult neoplasm is not medically necessary in juvenile dermatomyositis.
inv-24: Inflammatory Muscle Diseases
MRI without contrast of a single site is medically necessary when any of the following purposes are present:
Single-site MRI without contrast is sufficient for these purposes.
inv-25: Juvenile Dermatomyositis Imaging
Specific imaging deemed medically necessary for juvenile dermatomyositis:
MRI preferred over CT for soft tissue evaluation.
inv-26: Osgood-Schlatter Disease
Coverage stance for Osgood-Schlatter disease
inv-27: Popliteal (Baker) Cyst
Imaging pathway for suspected Baker cyst in children
Ultrasound has high sensitivity and specificity compared with MRI.
MRI provides additional intraarticular detail when clinically relevant.
inv-28: SCFE — Medical Necessity Criteria
Covered when the following are met for suspected SCFE:
Plain films are first-line.
inv-29: Tarsal Coalition / Club Foot / Vertical Talus — Medical Necessity Criteria
Covered when the following are met for suspected congenital foot anomalies:
Radiographs are first-line for tarsal coalition, club foot (older children), and vertical talus.
Advanced imaging when radiographs insufficient.
inv-30: Femoral Anteversion / Tibial Torsion — Medical Necessity Criteria
Covered when the following are met for suspected rotational deformities:
These guidelines include certain procedures that eviCore does not review for Cigna. Refer to the current Cigna CPT code list to determine which high‑technology imaging procedures are managed directly by Cigna rather than routed through eviCore for review.
Advanced imaging should only be obtained when a pertinent clinical evaluation (history, focused exam, appropriate labs) and basic imaging such as plain x‑ray or ultrasound have been performed and when the results will affect individual management decisions. Imaging requests that will not change management are not indicated.
When plain x‑rays are diagnostic for a non‑complex condition, additional advanced imaging is not medically necessary. Exceptions include complex (comminuted or displaced) joint fractures that require MRI or CT without contrast for preoperative planning, or cases where x‑ray is non‑diagnostic and further imaging will change management.
Advanced imaging is not medically necessary for commonly benign superficial lesions such as ganglion cysts, sebaceous cysts, hematomas, and subcutaneous lipomas. Ultrasound or MRI may be used selectively when clinical features warrant or when surgical planning requires further characterization, but routine advanced imaging for these entities is discouraged.
Acute compartment syndrome is a clinical diagnosis and a surgical emergency; advanced imaging is not medically necessary for diagnosis. Management should rely on clinical assessment and compartment pressure measurement rather than CT or MRI.
Hip ultrasound is not medically necessary for infants older than 6 months because plain radiographs become more reliable with femoral head ossification. For infants >6 months, plain x‑ray is the preferred initial study unless specific clinical circumstances indicate otherwise.
Ultrasound is useful for assessing effusion or soft‑tissue fluid collections, but it is not a required prerequisite before ordering MRI or CT. The absence of an ultrasound should not preclude appropriately indicated advanced imaging when clinical justification exists.
For juvenile idiopathic arthritis, MRI is medically necessary in specific situations (e.g., when ultrasound is inconclusive and MRI findings would alter management, diagnostic uncertainty prior to drug therapy, treatment monitoring, or to select a biopsy site). However, routine MRI for follow‑up is not medically necessary except for annual TMJ MRI to detect silent TMJ arthritis.
In juvenile dermatomyositis, routine screening for occult neoplasm is not medically necessary. Imaging is limited to indications such as confirming diagnosis with MRI to avoid biopsy, following progressive muscle calcification with CT or MRI, or systemic evaluation (CT chest/abdomen/pelvis with contrast) when palpable lymphadenopathy or hepatosplenomegaly is present.
Osgood‑Schlatter disease is diagnosed clinically with plain x‑ray correlation and treated conservatively; advanced imaging is not indicated for routine evaluation of this traction apophysitis of the tibial tubercle.
Ultrasound may be medically necessary in infants with nonossified tarsal bones to characterize cartilaginous structures, but it is not required prior to MRI or CT when those advanced studies are otherwise appropriate for the clinical question.
Repeat imaging of the same body area is unnecessary unless there is documented progression, new onset, or a clear rationale showing repeat imaging will affect management. Conservative therapy should be continued when clinically appropriate prior to repeating advanced studies.
Following a positive plain x‑ray, further advanced imaging is generally not medically necessary except for specific reasons such as complex (comminuted or displaced) intra‑articular fractures requiring surgical planning, assessment of healing when x‑ray is inadequate, or other explicitly stated indications where advanced imaging will change management.
Reiterating exclusions for benign superficial entities: advanced imaging is typically unnecessary for ganglion cysts, sebaceous cysts, hematomas, and subcutaneous lipomas, and surveillance of many benign bone lesions is adequately performed with plain radiographs.
Routine ultrasound screening of neonates and infants without DDH risk factors is not recommended. Hip ultrasound is medically necessary only within specified age/risk windows (for example, infants <4 months with risk factors); routine population screening outside those criteria is not supported.
MRI is not medically necessary for routine treatment follow‑up in JIA, with the exception that MRI TMJ (CPT 70336) is medically necessary annually to screen for silent TMJ arthritis in affected children.
Routine screening for occult neoplasm in juvenile dermatomyositis is not medically necessary; imaging is reserved for diagnostic confirmation, monitoring of progressive calcification, or systemic concerns supported by exam and symptoms.
Providers should note that certain procedure codes referenced in these guidelines may require prior authorization per payer arrangements. Additionally, some procedures listed in the document are not reviewed by eviCore for Cigna; consult the Cigna CPT code list for the current set of high‑technology imaging procedures and follow payer‑specific prior authorization processes for the CPT codes associated with musculoskeletal MRI, CT, and ultrasound.
Indications and When Imaging Is Medically Necessary
inv-140: General indications for advanced pediatric musculoskeletal imaging
inv-141: Modality selection for pediatric musculoskeletal conditions
inv-142: Suspected stress or occult fracture in high-risk anatomic sites
inv-143: Soft tissue mass with concerning features
inv-144: Soft tissue mass with negative x-ray and abnormal ultrasound
inv-145: Limping child with suspected trauma
inv-146: Limping child with suspected infection
inv-147: Developmental dysplasia of the hip (DDH)
inv-148: AVN / Osteonecrosis / Legg-Calvé-Perthes disease
inv-149: Screening of other children (contacts) in suspected physical abuse
inv-150: Infection / Osteomyelitis
inv-151: Effusion or soft tissue fluid collection
inv-152: Suspected retained soft tissue foreign body
inv-153: Suspected or established CRMO
inv-154: Inflammatory muscle disease / juvenile dermatomyositis
inv-155: Inflammatory muscle disease — MRI without contrast of a single site
inv-156: Popliteal (Baker) cyst
inv-157: Osgood-Schlatter disease
inv-158: Suspected SCFE
inv-159: Suspected congenital foot anomaly
inv-160: Femoral anteversion / tibial torsion preoperative assessment
Procedure Codes and CPT References
| No codes listed |
| 73218 | MRI Upper Extremity non-joint without contrast |
| 73219 | MRI Upper Extremity non-joint with contrast |
| 73220 | MRI Upper Extremity non-joint without and with contrast |
| 73221 | MRI Upper Extremity joint without contrast |
| 73222 | MRI Upper Extremity joint with contrast |
| 73223 | MRI Upper Extremity joint without and with contrast |
| 73718 | MRI Lower Extremity non-joint without contrast |
| 73719 | MRI Lower Extremity non-joint with contrast |
| 73720 | MRI Lower Extremity non-joint without and with contrast |
| 73721 | MRI Lower Extremity joint without contrast |
| 73200 | CT Upper Extremity without contrast |
| 73201 | CT Upper Extremity with contrast |
| 73202 | CT Upper Extremity without and with contrast |
| 73700 | CT Lower Extremity without contrast |
| 73701 | CT Lower Extremity with contrast |
| 73702 | CT Lower Extremity without and with contrast |
| 71250 | CT Chest without contrast |
| 71260 | CT Chest with contrast |
| 74160 | CT Abdomen with contrast |
| 72193 | CT Pelvis with contrast |
| 76881 | Ultrasound, extremity, nonvascular; complete joint |
| 76882 | Ultrasound, extremity, nonvascular; limited, anatomic specific for focal abnormality |
| 76885 | Ultrasound, infant hips; dynamic (requiring physician manipulation) |
| 76886 | Ultrasound, infant hips; limited, static (not requiring physician manipulation) |
| 76604 | Ultrasound, upper back |
| 76705 | Ultrasound, lower back |
| 76999 | Ultrasound, other soft tissue areas not otherwise specified |
| 93922 | Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries |
| 93923 | Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries |
| 93930 | Duplex scan of upper extremity arteries or arterial bypass grafts; complete bilateral |
| 76881 | Ultrasound, with or without guidance; limited, anatomic specific (e.g., hip) |
| 76882 | Ultrasound, complete, anatomic specific (e.g., hip) |
| 76885 | Ultrasound, neonatal, hip, unilateral |
| 76886 | Ultrasound, neonatal, hip, bilateral |
| 73721 | MRI lower extremity joint without contrast (hip region referenced) |
| 73723 | MRI lower extremity joint without and with contrast |
| 73700 | CT lower extremity (without contrast) — used as alternative to MRI |
| CT without contrast | CT scan without contrast (site-specific CPT codes noted elsewhere) |
| 70336 | MRI TMJ (medically necessary annually for silent TMJ arthritis screening in JIA) |
| 76498 | Whole body MRI (medically necessary for CRMO in specific situations) |
| 73700 | CT without contrast of lower extremity (listed for following progressive calcification) |
| 73718 | MRI (listed for following progressive calcification in muscles) |
| 71260 | CT Chest (listed for juvenile dermatomyositis with lymphadenopathy or hepatosplenomegaly) |
| 74177 | CT Abdomen and Pelvis with contrast (listed for juvenile dermatomyositis with lymphadenopathy or hepatosplenomegaly) |
| 73700 | CT without contrast of lower extremity (as cited for following calcification) |
| 73718 | MRI of lower extremity (as cited for following progressive calcification) |
| 71260 | CT chest (with contrast indicated for adenopathy/hepatosplenomegaly) |
| 74177 | CT abdomen and pelvis with contrast (indicated for adenopathy/hepatosplenomegaly) |
| plain x-ray | Anteroposterior and lateral (frog-leg or cross-table lateral) radiographs — initial imaging for hips and foot anomalies |
Authorization, Documentation, and Ordering Guidance
Prior authorization and eviCore review note
These guidelines include procedures that eviCore does not review for Cigna; providers should refer to the Cigna CPT code list for the current list of high‑tech imaging procedures reviewed by eviCore when determining whether prior authorization from eviCore is required.
Prior authorization not specified in this excerpt
This excerpt is a table of contents and does not specify any prior authorization rules or payer prior‑auth processes for individual studies.
Prior authorization — not specified in this fragment
This fragment contains section listings and page numbers and does not state specific prior authorization requirements.
Provider prior authorization for listed procedure codes
The listed CPT procedure codes (MRI, CT, ultrasound and related musculoskeletal imaging CPTs) are associated with services managed by eviCore for Cigna and may require authorization per payer arrangements; providers should confirm authorization requirements for the specific CPT code requested.
- See Procedure Codes Associated with Musculoskeletal Imaging (MSP.GG.ProcedureCodes.C) for CPT enumerations.
Coordinated imaging session recommended
When multiple body areas require MRI, obtain imaging of all necessary areas in the same session and coordinate exam selection with the imaging facility to minimize repeat studies and anesthesia exposure.
Advanced imaging prior authorization guidance
Requests for MRI or CT for soft tissue masses or bone lesions should document prior imaging and clinical rationale; CT is indicated only when MRI is contraindicated or unavailable.
- Plain x‑rays are required prior to advanced imaging for masses and bone lesions.
- If ultrasound is abnormal and x‑ray is negative, MRI with and without contrast is medically necessary; CT is the alternative if MRI contraindicated.
Advanced imaging sequencing (prior auth guidance)
Clinical sequencing is required for hip/limb evaluations: begin with plain radiographs for trauma, use ultrasound for hip effusion/DDH screening in defined age windows, and reserve MRI/CT for situations when plain films or ultrasound are non‑diagnostic; prior authorization may be required if these prior steps are not documented.
- Follow-up x‑rays at 7–10 days are expected when initial films are negative and symptoms persist.
- DDH ultrasound screening is indicated in specific age/risk windows (4 weeks–4 months).
Prior authorization for advanced imaging
Advanced imaging (MRI, CT) is medically necessary for the listed clinical indications in the guidelines; when prior authorization is required by the payer, providers should obtain authorization per payer processes for the modality CPT codes requested.
Whole body MRI for CRMO
Whole body MRI (CPT 76498) is medically necessary for suspected CRMO when characteristic MR findings would obviate biopsy and for monitoring established CRMO every 6–12 months; documentation of the clinical indication should accompany authorization requests.
- Indications: suspected CRMO to avoid biopsy; surveillance every 6–12 months for established CRMO.
Site-specific MRI/CT studies
Certain site‑specific MRI and CT studies (for example annual TMJ MRI CPT 70336 and CT/MRI for juvenile dermatomyositis progressive calcification) are specified as medically necessary in defined contexts and may require documentation of the indication when requesting prior authorization.
Baker cyst initial imaging
For suspected Baker (popliteal) cyst, ultrasound (CPT 76881/76882) is the medically necessary initial study; if ultrasound is non‑diagnostic or for preoperative planning, MRI without contrast (CPT 73721) is medically necessary and should be documented when requesting authorization.
Juvenile dermatomyositis imaging
For juvenile dermatomyositis, MRI without contrast is medically necessary to confirm diagnosis and may avoid biopsy; CT (CPT 73700) or MRI (CPT 73718) may be used to follow progressive muscle calcification, and CT chest/abdomen/pelvis with contrast is indicated for palpable adenopathy or hepatosplenomegaly—document indications when requesting advanced imaging.
Prior authorization for advanced imaging modalities
Advanced imaging modalities (MRI, CT, ultrasound) are designated medically necessary for the pediatric conditions listed when indications are met after initial radiographs or other required steps; providers should follow the guideline‑specified prerequisites and obtain prior authorization per payer policy when applicable.
These guidelines state that some procedures are not reviewed by eviCore for Cigna; refer to the Cigna CPT code list and the CRMO/whole‑body MRI section for CPT 76498 when documenting necessity and seeking authorization.
No step therapy requirements in this excerpt
No step therapy requirements are present in this excerpt; there are no payer‑mandated trial sequences described beyond guideline‑directed conservative care and imaging sequencing.
No step therapy rules present
No step therapy rules are specified in this content.
Conservative care recommended before advanced imaging
Provider‑directed conservative care (for example R.I.C.E., NSAIDs, immobilization, home exercise or physical medicine) should generally be attempted prior to advanced imaging unless the guideline specifically supports immediate advanced imaging or the imaging results will affect immediate management.
- Conservative care examples include rest/ice/compression/elevation, NSAIDs, analgesics, corticosteroids, viscosupplementation, home exercise, physical medicine, or immobilization.
Plain radiographs and conservative care expected before advanced imaging
For many fracture and stress/occult fracture evaluations, plain radiographs and/or a period of conservative care or follow‑up radiographs (commonly 7–10 days or 10 days of conservative care) are expected before advanced imaging unless the fracture is in a high‑risk site where immediate MRI/CT is indicated.
- High‑risk sites (pelvis, sacrum, hip, femur, tibia, tarsal navicular, proximal 5th metatarsal, scaphoid) may require MRI/CT immediately if x‑ray non‑diagnostic.
- For other sites, obtain follow‑up x‑rays after ~10 days of conservative care before MRI/CT unless initial non‑diagnostic x‑ray was obtained ≥14 days after symptom onset.
Conservative care follow-up for stress/occult fractures
When conservative care is used for suspected stress/occult fractures outside high‑risk sites, follow-up plain x‑rays after approximately 10 days are expected; if follow‑up films remain non‑diagnostic, MRI or CT without contrast is medically necessary.
- Exception: if initial non‑diagnostic x‑ray was obtained ≥14 days after symptom onset, advanced imaging may be indicated without additional conservative care.
Imaging stepwise approach (x‑ray → ultrasound → MRI/CT)
The guidelines specify a stepwise imaging approach: begin with plain radiographs for trauma and most evaluations, use ultrasound for hip effusion and DDH screening in defined age/risk windows, and reserve MRI for cases where plain films or ultrasound are non‑diagnostic or for preoperative/postreduction assessment; CT is used if MRI is contraindicated or unavailable.
Plain radiography first-line before MRI/CT
Plain radiography is the initial study and may be all that is necessary prior to progressing to MRI or CT; advanced imaging should be pursued only when radiographs are inconclusive or when results will change management.
Preferred initial modality in infants
In infants with nonossified tarsal bones (e.g., club foot evaluation), ultrasound may be used preferentially to characterize cartilaginous tarsal bones and alignment prior to CT or MRI when appropriate.
Refer to customer's benefit plan for medical necessity and authorization
Providers and reviewers should refer to the applicable customer's benefit plan document and relevant coverage policies when documenting medical necessity and when determining whether prior authorization is required for a requested study.
No documentation requirements present in this excerpt
No specific documentation requirements are present in this excerpt; the content is section listings and page numbers.
No documentation requirements in table of contents
No documentation requirements are specified in the table‑of‑contents portion of the document.
Provide recent plain x‑ray results and clinical evaluation
Requesting providers should have results of plain x‑rays performed after onset or change of current symptoms available and document the clinical evaluation (history and exam) when ordering advanced imaging.
- Plain x‑rays performed after the current episode of symptoms started or changed need to be available to the requesting provider.
Clinical evaluation and plain radiographs required
A pertinent clinical evaluation including detailed history, focused physical examination, and plain x‑rays should be performed and documented prior to consideration of advanced imaging for fracture, mass, or other indications.
- Meaningful technological contact (telehealth, phone, electronic messaging) can serve as pertinent clinical evaluation.
Clinical evaluation and plain x‑ray documentation for bone lesions
For bone lesions, document a detailed history and focused exam and obtain plain x‑rays of the entire bone containing the lesion prior to advanced imaging; imaging for preoperative planning or diagnostic uncertainty should be clearly justified in the request.
- Surveillance of benign bony lesions is with plain x‑ray; MRI/CT required if diagnosis uncertain or for preoperative planning.
Required clinical documentation
Required clinical documentation includes history and focused exam identifying suspected etiology (trauma, infection, or other), localization of symptoms, and prior plain radiograph findings and clinical course when requesting follow‑up or advanced imaging.
Document imaging rationale and patient age for contact/abuse cases
For contact children and suspected abuse cases, document the child’s age, clinical examination findings, and rationale for the imaging modality chosen (e.g., neuroimaging in contacts <12 months; skeletal survey in contacts 12–24 months).
- Contacts <12 months: neuroimaging (CT head or MRI brain) and skeletal survey.
- Contacts 12–24 months: skeletal survey.
Required clinical evaluation prior to advanced imaging
A pertinent clinical evaluation (history, exam, and plain x‑rays) should be performed and documented prior to considering advanced imaging; the indication must specify how advanced imaging will affect management.
Clinical indication must document specific reason for advanced imaging
When ordering advanced imaging, the clinical indication must document the specific reason (for example: biopsy site selection, concern for progression, treatment monitoring, or preoperative planning) to support medical necessity.
Clinical documentation to support advanced imaging
Document clinical suspicion (for example limp, groin/thigh/knee pain, restricted hindfoot motion, nonossified tarsal bones, or rotational deformity) and provide prior plain radiograph results when ordering MRI, CT, or ultrasound for pediatric musculoskeletal conditions.
Coverage determinations and plan terms
Coverage determinations require consideration of the applicable benefit plan document, laws/regulations, relevant collateral materials (including coverage policies), and the specific facts of the situation; conflicts are resolved by the customer's benefit plan document.
No explicit denial triggers present
This excerpt (table of contents) does not present explicit denial triggers.
No denial rules in this fragment
No denial rules are present in the table‑of‑contents portion of this document fragment.
Denial risk if clinical evaluation or basic imaging missing
Advanced imaging requests may be denied if a pertinent clinical evaluation (history, physical exam, labs) and basic imaging such as plain x‑rays or ultrasound were not performed or documented prior to the advanced imaging request.
Denial risk when plain x‑rays already diagnostic
Advanced imaging may be denied if plain x‑rays are positive and the case is not complex; further advanced imaging is not medically necessary except for complex joint fractures or other stated indications.
Plain x‑ray prerequisite — denial risk
Advanced imaging requests may be denied if plain x‑rays were not performed first when required by the guideline (for example stress/occult fractures and soft tissue/bone mass evaluations).
Trauma imaging sequencing — denial risk
Failure to obtain initial plain x‑rays for suspected trauma, or failure to obtain follow‑up x‑rays at 7–10 days when symptoms persist after negative initial films, may risk denial when advanced imaging is requested without documented clinical indication.
DDH ultrasound appropriateness — denial risk
Requesting DDH screening hip ultrasound outside the recommended risk‑factor window (not between 4 weeks and 4 months without qualifying risk factors), or ordering hip ultrasound for infants older than 6 months when plain x‑ray is preferred, may be denied.
- Screening ultrasound medically necessary for infants 4 weeks–4 months with risk factors; hip ultrasound NOT medically necessary for infants >6 months when x‑ray is preferred.
MRI may be denied if diagnosis certain on x‑ray
Requests for MRI may be denied if the diagnosis is already certain on plain x‑ray or if the imaging will not change management.
Denial risk for incomplete abuse imaging
Failure to perform an indicated skeletal survey or appropriate CT/MRI for suspected spine/head injuries may lead to denial of coverage for alternative or incomplete evaluations.
JIA routine MRI follow‑up may be unsupported
Requests for routine MRI for follow‑up of juvenile idiopathic arthritis (except annual TMJ screening) may be unsupported since routine MRI follow‑up is not medically necessary.
- MRI TMJ (CPT 70336) is medically necessary annually for silent TMJ arthritis; other routine MRI follow‑up is not medically necessary.
Limit imaging in juvenile dermatomyositis to specified indications
Ordering CT/MRI for juvenile dermatomyositis should be limited to specified indications (confirming diagnosis, following calcification, or systemic evaluation when adenopathy/hepatosplenomegaly present); inappropriate routine imaging may be denied.
SCFE imaging sequence — denial risk
Failure to obtain plain AP and lateral (frog‑leg or cross‑table lateral) x‑rays of both hips may lead to missed SCFE diagnosis and could risk denial if diagnostic imaging steps are not followed; MRI is medically necessary when radiographs are negative but suspicion persists.
Congenital foot anomalies — follow x‑ray first rule
Not performing initial plain radiographs for suspected tarsal coalition, club foot, or vertical talus before advanced imaging may not follow guideline‑recommended imaging sequence and could risk denial; use ultrasound in infants with nonossified bones when appropriate.
Prior Authorization and Utilization Management
Contrast Use and Anesthesia Considerations
Recommended Imaging Frequency and Follow-up Intervals
Not Medically Necessary / Exclusions
CT should not be used to replace MRI solely to avoid sedation. Use CT in place of MRI only when CT is specifically recommended by the guideline for the clinical question or when MRI is contraindicated or unavailable.
Advanced imaging is not covered for acute compartment syndrome, which is a clinical diagnosis, and is generally not necessary for benign superficial lesions such as ganglion cysts, sebaceous cysts, hematomas, and subcutaneous lipomas. Use of MRI or CT for these indications is not routinely supported.
Routine screening hip ultrasound for neonates and infants without risk factors for developmental dysplasia of the hip is not recommended. Ultrasound is medically necessary only within defined age and risk windows (for example, infants 4 weeks–4 months with risk factors) or when directed by clinical findings or treatment.
Routine MRI for follow‑up of juvenile idiopathic arthritis is not medically necessary except for the specified annual TMJ MRI (CPT 70336) used to screen for silent TMJ arthritis.
Reaffirming that routine population screening hip ultrasound in neonates/infants without DDH risk factors is not supported; ultrasound screening should be limited to those meeting the guideline's age and risk criteria.
The guideline's stance is consistent across sections: routine hip ultrasound screening of neonates/infants without documented DDH risk factors is not medically necessary, and follow‑up sonography is directed by specific Graf classifications or treatment needs.
Policy Background and Scope
These coverage policies are intended to guide interpretation of standard Cigna benefit plans and assist medical directors and other clinicians in making medical necessity and coverage determinations. They are not treatment recommendations, and the applicable customer's benefit plan document supersedes the policy if conflicts arise. Providers should use the guidelines to document clinical evaluation, prior imaging, and rationale demonstrating how advanced imaging will affect management decisions.
Terms and Abbreviations
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.